Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

3.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.4K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

657
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
657
Immunological Memory01:23

Immunological Memory

17.8K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
17.8K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

2.7K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.7K
Development of Immunocompetence01:22

Development of Immunocompetence

1.1K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurement of the inclusive and fiducial <math></math> production cross-sections in the lepton+jets channel in <i>pp</i> collisions at <math> </math> with the ATLAS detector.

The European physical journal. C, Particles and fields·2019
Same author

Prompt and non-prompt <math></math> and <math></math> suppression at high transverse momentum in <math></math> Pb+Pb collisions with the ATLAS experiment.

The European physical journal. C, Particles and fields·2019
Same author

Measurement of colour flow using jet-pull observables in <math></math> events with the ATLAS experiment at <math> </math>.

The European physical journal. C, Particles and fields·2019
Same author

Performance of missing transverse momentum reconstruction with the ATLAS detector using proton-proton collisions at <math> </math>.

The European physical journal. C, Particles and fields·2019
Same author

Operation and performance of the ATLAS Tile Calorimeter in Run 1.

The European physical journal. C, Particles and fields·2019
Same author

Search for electroweak production of supersymmetric particles in final states with two or three leptons at <math> </math> with the ATLAS detector.

The European physical journal. C, Particles and fields·2019

Related Experiment Video

Updated: Mar 22, 2026

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.8K

Patient education programme on immunotherapy in multiple sclerosis (PEPIMS): a controlled rater-blinded study.

S Köpke1, J Kasper2, P Flachenecker3

  • 11 Institute of Social Medicine, University of Lübeck, Lübeck, Germany.

Clinical Rehabilitation
|April 14, 2016
PubMed
Summary

A new education program significantly increased informed choices for multiple sclerosis patients regarding disease-modifying therapies. This evidence-based intervention improved understanding of risks and decision-making in rehabilitation settings.

Keywords:
Educationcontrolled clinical trialmultiple sclerosisneurological rehabilitation

More Related Videos

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

2.6K
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

13.0K

Related Experiment Videos

Last Updated: Mar 22, 2026

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.8K
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

2.6K
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

13.0K

Area of Science:

  • Neurology
  • Patient Education
  • Evidence-Based Practice

Background:

  • Multiple sclerosis (MS) management involves complex treatment decisions, particularly regarding disease-modifying therapies (DMTs).
  • Patients often require comprehensive information to make informed choices about their treatment.
  • Rehabilitation settings offer a crucial opportunity to deliver patient-centered education.

Purpose of the Study:

  • To evaluate the effectiveness of a multi-component, evidence-based education program on DMTs for individuals with MS.
  • To assess the impact of the program on informed choice, risk knowledge, autonomy, and psychological well-being.

Main Methods:

  • A controlled trial was conducted across three neurological rehabilitation centers, involving two consecutive patient cohorts.
  • The intervention group (IG) received a six-hour nurse-led education program and brochure, while the control group (CG) received standard information.
  • Informed choice, defined as adequate risk knowledge and attitude-uptake congruency, was the primary outcome.

Main Results:

  • The intervention group demonstrated a significantly higher rate of informed choice (47% vs. 23%, P=0.004).
  • Adequate risk knowledge was significantly improved in the IG immediately post-intervention (54% vs. 31%, P=0.007), though this effect diminished at six months.
  • No significant differences were observed between groups regarding attitude towards DMTs, DMT status, autonomy preferences, or decisional conflict at six months.

Conclusions:

  • Implementing an evidence-based education program on MS DMTs in rehabilitation settings effectively enhances informed patient choices.
  • The findings highlight the importance of structured educational interventions in improving patient decision-making for chronic disease management.